Learn about animal and model selection for preclinical immuno-oncology studies.

Read our Preclinical Immuno-Oncology Digest:

Immuno-Oncology studies require sophisticated endpoints to deliver meaningful, decision-supporting data. In this synopsis you will learn how to plan your immuno-oncology study to give you the data you need by:

  • Identifying and distinguishing between host animals
  • Assessing immunomodulation
  • Finding out the advantages to using orthotopic implantation for both solid and hematological models
  • Recognizing the differences in immune composition between tumor models and why this is important
  • Learning how targeting “cold” tumors is put into practice
  • Knowing the relative tumor response to a desired combination partner
  • Using molecular characterization and RNAseq data to influence model selection

MI Bioresearch | Advancing Your Preclinical Oncology